Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125238221 | 12523822 | 1 | I | 20160510 | 20160620 | 20160704 | 20160704 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-052084 | BRISTOL MYERS SQUIBB | 73.43 | YR | F | Y | 0.00000 | 20160704 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125238221 | 12523822 | 1 | PS | METFORMIN HYDROCHLORIDE. | METFORMIN HYDROCHLORIDE | 1 | Oral | 1 DF, UNK | U | 20357 | 1 | DF | FILM-COATED TABLET | ||||||
125238221 | 12523822 | 2 | SS | LERCANIDIPINE | LERCANIDIPINE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
125238221 | 12523822 | 3 | SS | TELMISARTAN. | TELMISARTAN | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
125238221 | 12523822 | 4 | SS | REPAGLINIDE. | REPAGLINIDE | 1 | Oral | 4 MG, UNK | U | 0 | 4 | MG | |||||||
125238221 | 12523822 | 5 | SS | DESLORATADIN | DESLORATADINE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
125238221 | 12523822 | 6 | SS | XELEVIA | SITAGLIPTIN PHOSPHATE | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
125238221 | 12523822 | 7 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 1 DF, UNK | U | 0 | 1 | DF | |||||||
125238221 | 12523822 | 8 | C | NAPROXEN. | NAPROXEN | 1 | Unknown | UNK | U | 0 | |||||||||
125238221 | 12523822 | 9 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125238221 | 12523822 | 1 | Diabetes mellitus |
125238221 | 12523822 | 2 | Hypertension |
125238221 | 12523822 | 3 | Hypertension |
125238221 | 12523822 | 4 | Diabetes mellitus |
125238221 | 12523822 | 5 | Product used for unknown indication |
125238221 | 12523822 | 6 | Diabetes mellitus |
125238221 | 12523822 | 7 | Dyslipidaemia |
125238221 | 12523822 | 8 | Product used for unknown indication |
125238221 | 12523822 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125238221 | 12523822 | HO |
125238221 | 12523822 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125238221 | 12523822 | Alanine aminotransferase increased | |
125238221 | 12523822 | Aspartate aminotransferase increased | |
125238221 | 12523822 | Cough | |
125238221 | 12523822 | Eosinophilia | |
125238221 | 12523822 | Feeling cold | |
125238221 | 12523822 | Gamma-glutamyltransferase increased | |
125238221 | 12523822 | Hypoxia | |
125238221 | 12523822 | Liver injury | |
125238221 | 12523822 | Myalgia | |
125238221 | 12523822 | Pleural effusion | |
125238221 | 12523822 | Pulmonary mass | |
125238221 | 12523822 | Pyrexia | |
125238221 | 12523822 | Rash | |
125238221 | 12523822 | Rash maculo-papular | |
125238221 | 12523822 | Toxic skin eruption |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125238221 | 12523822 | 1 | 20160518 | 0 | ||
125238221 | 12523822 | 2 | 20160518 | 0 | ||
125238221 | 12523822 | 3 | 20160518 | 20160518 | 0 | |
125238221 | 12523822 | 4 | 20160518 | 0 | ||
125238221 | 12523822 | 5 | 20160518 | 0 | ||
125238221 | 12523822 | 6 | 20160518 | 0 | ||
125238221 | 12523822 | 7 | 20160518 | 0 | ||
125238221 | 12523822 | 8 | 20160411 | 20160418 | 0 | |
125238221 | 12523822 | 9 | 20160411 | 20160418 | 0 |